Delcath Systems PE Ratio 2010-2025 | DCTH
Current and historical p/e ratio for Delcath Systems (DCTH) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Delcath Systems PE ratio as of June 17, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Delcath Systems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-17 | 14.63 | 0.00 | |
| 2025-03-31 | 12.73 | $-0.50 | 0.00 |
| 2024-12-31 | 12.04 | $-0.98 | 0.00 |
| 2024-09-30 | 9.03 | $-1.35 | 0.00 |
| 2024-06-30 | 8.37 | $-2.55 | 0.00 |
| 2024-03-31 | 4.77 | $-2.65 | 0.00 |
| 2023-12-31 | 4.16 | $-2.97 | 0.00 |
| 2023-09-30 | 4.05 | $-3.35 | 0.00 |
| 2023-06-30 | 5.83 | $-3.13 | 0.00 |
| 2023-03-31 | 5.75 | $-3.73 | 0.00 |
| 2022-12-31 | 3.60 | $-3.96 | 0.00 |
| 2022-09-30 | 3.20 | $-3.79 | 0.00 |
| 2022-06-30 | 3.99 | $-3.81 | 0.00 |
| 2022-03-31 | 6.40 | $-3.59 | 0.00 |
| 2021-12-31 | 7.75 | $-3.63 | 0.00 |
| 2021-09-30 | 10.44 | $-3.55 | 0.00 |
| 2021-06-30 | 12.61 | $-3.77 | 0.00 |
| 2021-03-31 | 12.42 | $-4.71 | 0.00 |
| 2020-12-31 | 17.92 | $-111.74 | 0.00 |
| 2020-09-30 | 11.61 | $-111.13 | 0.00 |
| 2020-06-30 | 10.25 | $-1,117.11 | 0.00 |
| 2020-03-31 | 10.00 | $-1,172.36 | 0.00 |
| 2019-12-31 | 21.25 | $-1,142.86 | 0.00 |
| 2019-09-30 | 70.00 | $-1,142.86 | 0.00 |
| 2019-06-30 | 84.00 | $-314.29 | 0.00 |
| 2019-03-31 | 167.93 | $-5,442.86 | 0.00 |
| 2018-12-31 | 196.07 | $2,428.57 | 0.08 |
| 2018-09-30 | 1288.00 | $2,428.57 | 0.53 |
| 2018-06-30 | 1946.00 | $-3,340,249.86 | 0.00 |
| 2018-03-31 | 3605.00 | $-4,566,591.14 | 0.00 |
| 2017-12-31 | 32200.00 | $-35,362,564.00 | 0.00 |
| 2017-09-30 | 1000000.00 | $-555,066,964.00 | 0.00 |
| 2017-06-30 | 1000000.00 | $-633,004,897.00 | 0.00 |
| 2017-03-31 | 1000000.00 | $-1,174,876,770.00 | 0.00 |
| 2016-12-31 | 1000000.00 | $-1,301,724,090.00 | 0.00 |
| 2016-09-30 | 1000000.00 | $-1,235,221,690.00 | 0.00 |
| 2016-06-30 | 1000000.00 | $-1,390,394,100.00 | 0.00 |
| 2016-03-31 | 1000000.00 | $-1,438,423,700.00 | 0.00 |
| 2015-12-31 | 1000000.00 | $-1,911,330,000.00 | 0.00 |
| 2015-09-30 | 1000000.00 | $-2,068,965,400.00 | 0.00 |
| 2015-06-30 | 1000000.00 | $-2,778,325,000.00 | 0.00 |
| 2015-03-31 | 1000000.00 | $-3,187,191,999.00 | 0.00 |
| 2014-12-31 | 1000000.00 | $-3,556,650,198.00 | 0.00 |
| 2014-09-30 | 1000000.00 | $-3,945,812,797.00 | 0.00 |
| 2014-06-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2014-03-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2013-12-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2013-09-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2013-06-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2013-03-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2012-12-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2012-09-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2012-06-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2012-03-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2011-12-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2011-09-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2011-06-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2011-03-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2010-12-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2010-09-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2010-06-30 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2010-03-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| 2009-12-31 | 1000000.00 | $-3,999,999,996.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.510B | $0.037B |
| Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.550B | 80.39 |
| Thermo Fisher Scientific (TMO) | United States | $147.321B | 17.82 |
| Edwards Lifesciences (EW) | United States | $42.980B | 28.18 |
| IDEXX Laboratories (IDXX) | United States | $41.867B | 48.11 |
| Alcon (ALC) | Switzerland | $41.867B | 28.29 |
| DexCom (DXCM) | United States | $32.086B | 49.59 |
| IQVIA Holdings (IQV) | United States | $26.659B | 14.93 |
| Mettler-Toledo (MTD) | United States | $23.912B | 28.44 |
| STERIS (STE) | Ireland | $23.322B | 25.69 |
| Waters (WAT) | United States | $20.299B | 28.64 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.846B | 0.00 |
| Hologic (HOLX) | United States | $14.293B | 15.53 |
| Sysmex ADR (SSMXY) | Japan | $10.555B | 29.94 |
| Penumbra (PEN) | United States | $9.912B | 77.80 |
| Masimo (MASI) | United States | $8.638B | 31.86 |
| Globus Medical (GMED) | United States | $7.871B | 18.75 |
| Glaukos (GKOS) | United States | $5.703B | 0.00 |
| Teleflex (TFX) | United States | $5.194B | 8.57 |
| TransMedics (TMDX) | United States | $4.607B | 100.15 |
| Integer Holdings (ITGR) | United States | $4.154B | 21.77 |
| PROCEPT BioRobotics (PRCT) | United States | $3.266B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.418B | 14.40 |
| Veracyte (VCYT) | United States | $2.096B | 29.41 |
| Nihon Kohden (NHNKY) | Japan | $1.988B | 22.80 |
| Elekta AB (EKTAY) | Sweden | $1.903B | 17.10 |
| Alphatec Holdings (ATEC) | United States | $1.586B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.337B | 0.00 |
| Artivion (AORT) | United States | $1.271B | 119.08 |
| OPKO Health (OPK) | United States | $1.023B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.012B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.944B | 5.02 |
| Beta Bionics (BBNX) | United States | $0.790B | 0.00 |
| IRadimed (IRMD) | United States | $0.737B | 37.41 |
| SiBone (SIBN) | United States | $0.731B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.561B | 8.73 |
| RxSight (RXST) | United States | $0.549B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.506B | 11.86 |
| OrthoPediatrics (KIDS) | United States | $0.495B | 0.00 |
| AxoGen (AXGN) | United States | $0.434B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.413B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.412B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.390B | 0.00 |
| NeuroPace (NPCE) | United States | $0.354B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.342B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.318B | 8.47 |
| ClearPoint Neuro (CLPT) | United States | $0.313B | 0.00 |
| 908 Devices (MASS) | United States | $0.264B | 0.00 |
| Neuronetics (STIM) | United States | $0.230B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.228B | 13.82 |
| Alpha Tau Medical (DRTS) | Israel | $0.208B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.208B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.174B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.152B | 0.00 |
| CVRx (CVRX) | United States | $0.148B | 0.00 |
| LENSAR (LNSR) | United States | $0.145B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.135B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.133B | 0.00 |
| Accuray (ARAY) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.105B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.103B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.088B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.20 |
| EnVVeno Medical (NVNO) | United States | $0.075B | 0.00 |
| InspireMD (NSPR) | United States | $0.074B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.064B | 0.00 |
| Hyperfine (HYPR) | United States | $0.055B | 0.00 |
| Spectral AI (MDAI) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.047B | 0.00 | |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.030B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.47 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |